Ravali Tarigopula in Sulphur, Louisiana

Home Louisiana Sulphur

Ravali Tarigopula has Pulmonary Disease as her primary medical specialty. Their primary office is: 1327 Stelly Ln in Sulphur, Louisiana. There is an additional office location, for a total of two, for Ravali Tarigopula that can be viewed further down. They attended Sorry, her university is not listed and graduated in 2006 (around 18 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Ravali Tarigopula Office Phone and Directions

Ravali Tarigopula
1327 Stelly Ln
Sulphur, Louisiana 70663
626-376-2438

Patient Ratings
Please rate your experience with Ravali Tarigopula below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 626-376-2438

Enter a starting address:

Healthcare Info for Ravali Tarigopula

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS), HOSPITALIST, INTERNAL MEDICINE, SLEEP MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 2006
The Primary Medical Specialty for Ravali Tarigopula is listed as: Pulmonary Disease
Approximate Years of Experience: 18
PAC (PECOS ID)#: 0547427346
NPI #: 1285802892
NPI Created On: 02/16/2008
NPI Last Updated Listed as: 07/09/2021
Primary Taxonomy Code: 207R00000X
License Number:
MD.34174
Listed Gender: Female

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Humana
Blue Cross Blue Shield
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Telugu, Kannada, Hindi.

Services and Procedures include:

Examination of lung airways using an endoscope
Diagnostic testing in a pulmonary function lab
Demonstration and/or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (ippb) device
Determination of lung volumes using plethysmography
Measurement of lung diffusing capacity
Sleep monitoring of patient (6 years or older) in sleep lab
Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube
Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
New patient office or other outpatient visit, typically 45 minutes
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 50 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 15 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801654299

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801656353

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801656963

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $4

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801656997

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801657165

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $3

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801657323

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $50

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Context of payment:: Payment was made by a third party for participation in a market research study on behalf of GSK.

Record ID:: 801660311

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Payments Total: $16

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802129531

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802148714

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $18

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 802306319

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Additional Office Locations

1. Genesis Health System
1801 E 54th St
Davenport, IA 52807
100 Genesis Health Group
Group Members: 196

Phone: 626-376-2438

Enter a starting address:

Pulmonary Disease Professionals in Sulphur

1.
Clifford Courville

920 1st Ave
Sulphur, LA
Calcasieu Cameron Hospital Service District

Providers in the same medical group

1.Jon Aagaard

2001 N Gary Ave
Wheaton Il 60187-3055
Family Practice

2.Matthew Aaker

8055 W Ave
Castle Hills Tx 78213-1842
Optometry

3.Justin Aaker

3613 Williams Dr
Georgetown Tx 78628-1373
Ophthalmology

4.Mohammad Aalai

7005 35th Ave
Jackson Heights Ny 11372-3970
Physical Medicine And Rehabilitation

5.Carol Aalbers Cp

4560 S Carson St
Carson City Nv 89701-6915
Clinical Psychologist

6.Hina Aamir

602 S Atwood Rd
Bel Air Md 21014-4323
Psychiatry